Skip to contentE
Escalon Medical Corp
E
ESMCEscalon Medical Corp Q1 2024 · 10-Q
Revenue$2.95M$2.95M+13.1% vs Q1 2023 Net Income-$21.20K-$21.20KN/M vs Q1 2023 EPS Diluted$0.00$0.00N/M vs Q1 2023 Operating Income-$15,647N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Escalon Medical Corp · CIK 862668 · Engraved from SEC EDGAR
Free Cash Flowderived-$134,290N/M Margins · derivedOperating margin-0.5%+11.6 pt vs Q1 2023
Net margin-0.7%+11.6 pt vs Q1 2023
ended Sep 30, 2023 · filed Nov 17, 2023 · 48 d after period end